Immuneering Corp. (IMRX)
4.07
+0.04
(+0.99%)
USD |
NASDAQ |
Oct 02, 16:00
4.07
0.00 (0.00%)
After-Hours: 20:00
Immuneering Price : 4.07 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 4.10 | 4.145 | 4.02 | 4.07 | 588944.0 |
| Oct 01, 2026 | 4.10 | 4.17 | 4.01 | 4.03 | 538180.0 |
| Sep 30, 2026 | 4.16 | 4.23 | 4.09 | 4.095 | 596821.0 |
| Sep 29, 2026 | 4.16 | 4.16 | 4.065 | 4.13 | 574595.0 |
| Sep 28, 2026 | 4.25 | 4.25 | 4.125 | 4.16 | 598654.0 |
| Sep 25, 2026 | 4.36 | 4.40 | 4.255 | 4.27 | 513539.0 |
| Sep 24, 2026 | 4.36 | 4.380 | 4.20 | 4.34 | 590129.0 |
| Sep 23, 2026 | 4.62 | 4.65 | 4.355 | 4.38 | 552688.0 |
| Sep 22, 2026 | 4.50 | 4.665 | 4.45 | 4.61 | 590424.0 |
| Sep 21, 2026 | 4.55 | 4.57 | 4.38 | 4.44 | 540280.0 |
| Sep 18, 2026 | 4.46 | 4.52 | 4.415 | 4.48 | 1.078M |
| Sep 17, 2026 | 4.55 | 4.55 | 4.405 | 4.46 | 576435.0 |
| Sep 16, 2026 | 4.45 | 4.505 | 4.398 | 4.45 | 900508.0 |
| Sep 15, 2026 | 4.33 | 4.475 | 4.24 | 4.44 | 862690.0 |
| Sep 14, 2026 | 4.28 | 4.435 | 4.26 | 4.33 | 493768.0 |
| Sep 11, 2026 | 4.63 | 4.65 | 4.24 | 4.27 | 911043.0 |
| Sep 10, 2026 | 4.53 | 4.685 | 4.47 | 4.57 | 625141.0 |
| Sep 09, 2026 | 4.74 | 4.81 | 4.54 | 4.61 | 1.166M |
| Sep 08, 2026 | 4.82 | 4.885 | 4.685 | 4.78 | 1.044M |
| Sep 04, 2026 | 4.94 | 5.00 | 4.805 | 4.82 | 1.000M |
| Sep 03, 2026 | 5.085 | 5.105 | 4.93 | 5.04 | 424432.0 |
| Sep 02, 2026 | 4.85 | 5.055 | 4.80 | 5.02 | 678701.0 |
| Sep 01, 2026 | 4.90 | 4.985 | 4.84 | 4.85 | 435184.0 |
| Aug 31, 2026 | 5.00 | 5.01 | 4.862 | 4.99 | 587881.0 |
| Aug 28, 2026 | 5.21 | 5.214 | 4.935 | 4.99 | 793869.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
| Vericel Corp. | 40.15 |
| Biogen, Inc. | 219.88 |
Price Related Metrics
| Price to Book Value | 1.380 |
| Earnings Yield | -25.35% |
| Market Cap | 263.32M |